Johnson & Johnson revives the Kilmer Conference on sterility assurance and sterilization after a series of high-profile - and sometimes deadly - 'superbug' infections.
Johnson & Johnson (NYSE:JNJ) said today that it's planning to revive the sterility assurance and sterilization conference it ran for 27 years before closing up shop in 2003.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1EVdcvy
Cap comentari:
Publica un comentari a l'entrada